Konjac
Natural health product licensed in Canada
- Licence holder
- SBM giga inc.
- NPN or DIN-HM
- 80017135
- Status
- Inactive licence
- Licence date
- 25 March 2010
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| bêta-galactosidase Source : Aspergillus flavus var. oryzae Potency : 750 ALU Lactase | 166.7 mg | Not calculated |
| bêta-galactosidase Source : Plante entière Potency : 750 ALU Lactase | 166.7 mg | Not calculated |
| Glucomannane Source : Racine | 500 mg | Not calculated |
| Glucomannane Source : Amorphophallus konjac | 500 mg | Not calculated |
Non-medicinal ingredients
Gélatine, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 3 Tous les jours |
Uses authorised in Canada
Aide à réduire le taux de cholestérol (en réduisant l'absorption du cholestérol par le tractus gastro-intestinal) et le lactase aide à la digestion des aliments contenant du lactose (i.e. produits laitiers, lait).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80017135
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.